The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foxman, E. F.
Right arrow Articles by Gery, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foxman, E. F.
Right arrow Articles by Gery, I.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2002, 168: 2483-2492.
Copyright © 2002 by The American Association of Immunologists

Inflammatory Mediators in Uveitis: Differential Induction of Cytokines and Chemokines in Th1- Versus Th2-Mediated Ocular Inflammation

Ellen F. Foxman*, Meifen Zhang*, Stephen D. Hurst{dagger}, Tony Muchamuel{dagger}, Defen Shen*, Eric F. Wawrousek*, Chi-Chao Chan* and Igal Gery1,*

* National Eye Institute, National Institutes of Health, Bethesda, MD 20892; and {dagger} DNAX Research Institute, Palo Alto, CA 94304

Ocular inflammation leads to vision loss through the destruction and scarring of delicate tissues along the visual axis. To identify inflammatory mediators involved in this process, we used real time RT-PCR to quantify the expression of mRNA transcripts of 34 cytokines, 26 chemokines, and 14 chemokine receptors at certain time points during T cell-mediated ocular inflammation. We induced disease by adoptive transfer of Ag-specific Th1 or Th2 cells into recipients expressing the target Ag in their eyes. We also compared the mediator expression patterns seen in adoptive transfer-induced inflammation with that seen in mouse eyes developing experimental autoimmune uveoretinitis. In addition, we used laser capture microdissection to examine chemokine mRNA production by both retinal pigment epithelium cells and infiltrating leukocytes in inflamed eyes. Major findings included the following: 1) Three patterns of expression of the inflammation-related molecules were seen in recipients of adoptively transferred Th cells: preferential expression in Th1 recipients, or in Th2 recipients, or similar expression in both recipient groups. 2) In experimental autoimmune uveoretinitis, the inflammatory mediator expression pattern largely paralleled that seen in Th1-induced disease. 3) Both retinal pigment epithelium and infiltrating leukocytes expressed chemokine transcripts in distinct, but overlapping patterns in inflamed eyes. 4) Interestingly, trancripts of multiple cytokines, chemokines, and chemokine receptors were constitutively expressed in high levels in mouse eyes. Seven of these molecules have not been previously associated with the eye. These data underscore the multiplicity of mediators that participate in the pathogenesis of eye inflammation and point to upstream cytokines as potential therapeutic targets.




This article has been cited by other articles:


Home page
IOVSHome page
G. Shi, A. Maminishkis, T. Banzon, S. Jalickee, R. Li, J. Hammer, and S. S. Miller
Control of Chemokine Gradients by the Retinal Pigment Epithelium
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4620 - 4630.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Cox, G. Shi, H. Yin, B. P. Vistica, E. F. Wawrousek, C.-C. Chan, and I. Gery
Both Th1 and Th17 Are Immunopathogenic but Differ in Other Key Biological Activities
J. Immunol., June 1, 2008; 180(11): 7414 - 7422.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. B. Su, R. S. Grajewski, D. Luger, R. K. Agarwal, P. B. Silver, J. Tang, J. Tuo, C.-C. Chan, and R. R. Caspi
Altered Chemokine Profile Associated with Exacerbated Autoimmune Pathology under Conditions of Genetic Interferon-{gamma} Deficiency
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4616 - 4625.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Tuo, C. M. Bojanowski, M. Zhou, D. Shen, R. J. Ross, K. I. Rosenberg, D. J. Cameron, C. Yin, J. A. Kowalak, Z. Zhuang, et al.
Murine Ccl2/Cx3cr1 Deficiency Results in Retinal Lesions Mimicking Human Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3827 - 3836.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
R. Rajendram, S. Saraswathy, and N. A Rao
Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis
Br. J. Ophthalmol., April 1, 2007; 91(4): 531 - 537.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
K. Oh-i, H. Keino, H. Goto, N. Yamakawa, K. Murase, Y. Usui, T. Kezuka, J.-i. Sakai, M. Takeuchi, and M. Usui
Intravitreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in Rats
Br. J. Ophthalmol., February 1, 2007; 91(2): 237 - 242.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Fujimoto, C.-R. Yu, G. Shi, B. P. Vistica, E. F. Wawrousek, D. M. Klinman, C.-C. Chan, C. E. Egwuagu, and I. Gery
Pertussis Toxin Is Superior to TLR Ligands in Enhancing Pathogenic Autoimmunity, Targeted at a Neo-Self Antigen, by Triggering Robust Expansion of Th1 Cells and Their Cytokine Production
J. Immunol., November 15, 2006; 177(10): 6896 - 6903.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. T. Hikita, B. P. Vistica, H. R. Jones, J. R. Keswani, M. M. Watson, V. R. Ericson, G. S. Ayoub, I. Gery, and D. O. Clegg
Osteopontin is proinflammatory in experimental autoimmune uveitis.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4435 - 4443.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Wang, F. Bai, M. Pries, S. Buus, J. U. Prause, and M. H. Nissen
Identification of MHC class I h-2 kb/db-restricted immunogenic peptides derived from retinal proteins.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3939 - 3945.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Takase, C.-R. Yu, D.-I. Ham, C.-C. Chan, J. Chen, B. P. Vistica, E. F. Wawrousek, S. K. Durum, C. E. Egwuagu, and I. Gery
Inflammatory processes triggered by TCR engagement or by local cytokine expression: differences in profiles of gene expression and infiltrating cell populations
J. Leukoc. Biol., September 1, 2006; 80(3): 538 - 545.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Chen, C. Fujimoto, B. P. Vistica, E. F. Wawrousek, B. Kelsall, and I. Gery
Active participation of antigen-nonspecific lymphoid cells in immune-mediated inflammation.
J. Immunol., September 1, 2006; 177(5): 3362 - 3368.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
H Takase, S Sugita, C Taguchi, Y Imai, and M Mochizuki
Capacity of ocular infiltrating T helper type 1 cells of patients with non-infectious uveitis to produce chemokines
Br. J. Ophthalmol., June 1, 2006; 90(6): 765 - 768.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
I. J. Crane, H. Xu, C. Wallace, A. Manivannan, M. Mack, J. Liversidge, G. Marquez, P. F. Sharp, and J. V. Forrester
Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis
J. Leukoc. Biol., March 1, 2006; 79(3): 435 - 443.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Hashida, N. Ohguro, K. Nakai, M. Kobashi-Hashida, S.-i. Hashimoto, K. Matsushima, and Y. Tano
Microarray Analysis of Cytokine and Chemokine Gene Expression after Prednisolone Treatment in Murine Experimental Autoimmune Uveoretinitis
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4224 - 4234.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H.-y. Zeng, X.-a. Zhu, C. Zhang, L.-P. Yang, L.-m. Wu, and M. O. M. Tso
Identification of Sequential Events and Factors Associated with Microglial Activation, Migration, and Cytotoxicity in Retinal Degeneration in rd Mice
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2992 - 2999.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
W.-K. Lim, C. Fujimoto, R. Ursea, S. P. Mahesh, P. Silver, C.-C. Chan, I. Gery, and R. B. Nussenblatt
Suppression of Immune-Mediated Ocular Inflammation in Mice by Interleukin 1 Receptor Antagonist Administration
Arch Ophthalmol, July 1, 2005; 123(7): 957 - 963.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Zheng, M. J. Kang, K. Crothers, Z. Zhu, W. Liu, C. G. Lee, L. A. Rabach, H. A. Chapman, R. J. Homer, D. Aldous, et al.
Role of Cathepsin S-Dependent Epithelial Cell Apoptosis in IFN-{gamma}-Induced Alveolar Remodeling and Pulmonary Emphysema
J. Immunol., June 15, 2005; 174(12): 8106 - 8115.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C.-H. Yang, I-M. Fang, C.-P. Lin, C.-M. Yang, and M.-S. Chen
Effects of the NF-{kappa}B Inhibitor Pyrrolidine Dithiocarbamate on Experimentally Induced Autoimmune Anterior Uveitis
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1339 - 1347.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. J. Kim, Z. Li, R. N. Fariss, D. F. Shen, S. P. Mahesh, C. Egwuagu, C.-R. Yu, C. N. Nagineni, C.-C. Chan, and R. B. Nussenblatt
Constitutive and Cytokine-Induced GITR Ligand Expression on Human Retinal Pigment Epithelium and Photoreceptors
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3170 - 3176.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. Curnow, K. Wloka, J. M. Faint, N. Amft, C. M. G. Cheung, V. Savant, J. Lord, A. N. Akbar, C. D. Buckley, P. I. Murray, et al.
Topical Glucocorticoid Therapy Directly Induces Up-Regulation of Functional CXCR4 on Primed T Lymphocytes in the Aqueous Humor of Patients with Uveitis
J. Immunol., June 1, 2004; 172(11): 7154 - 7161.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Greiner, C. C. Murphy, F. Willermain, L. Duncan, J. Plskova, G. Hale, J. D. Isaacs, J. V. Forrester, and A. D. Dick
Anti-TNF{alpha} Therapy Modulates the Phenotype of Peripheral Blood CD4+ T Cells in Patients with Posterior Segment Intraocular Inflammation
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 170 - 176.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.